Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’
Cytokinetics has been on a tear as the biotech pioneers more drugs to fight heart ailments
This San Francisco-based satellite company’s stock has doubled in the past three months
Ray Dalio says a risky AI market bubble is forming, but may not pop until the Fed tightens
AI is driving huge productivity gains for large companies, while small companies get left behind
Top Wall Street analysts pound the table for solid returns in these 3 stocks
Starboard aims to unlock the value of Fluor’s investment in nuclear tech company NuScale
Why Jana’s partnership with Travis Kelce could tip the balance and revive Six Flags’ business
Investor Lauren Taylor Wolfe says we are ‘absolutely’ in an AI bubble now
